Literature DB >> 11901931

Role of acid and bile in the genesis of Barrett's esophagus.

Werner K H Kauer1, Hubert J Stein.   

Abstract

Clinical and experimental studies have shown that acid and bile reflux are increased in patients who have Barrett's esophagus. The combination of both seems the key factor in the pathogenesis of Barrett's esophagus. This factor has been confirmed by immunohistochemical studies that show that environmental factors, such as acid and bile, are involved in the pathogenesis of Barrett's esophagus. There is a critical pH range between 3 and 6 in which bile acids exist in their soluble, un-ionized form; can penetrate cell membranes; and accumulate within mucosal cells. At a lower pH, bile acids are precipitated, and at a higher pH, bile acids exist in their noninjurious ionized form. Thus incomplete gastric acid suppression, as is the case with most medical treatment regimens for gastroesophageal reflux, may in fact predispose to the development of Barrett's esophagus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901931     DOI: 10.1016/s1052-3359(03)00064-4

Source DB:  PubMed          Journal:  Chest Surg Clin N Am        ISSN: 1052-3359


  9 in total

1.  Why Choosing the Roux-en-Y Gastric Bypass in a Morbid Obese with a History of a Failed Nissen Fundoplication Is Not a Dogma.

Authors:  Antonio Iannelli; Sébastien Frey; Niccolo Petrucciani
Journal:  Obes Surg       Date:  2020-11       Impact factor: 4.129

Review 2.  Barrett's esophagus and Barrett's carcinoma.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Jörg R Siewert
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

3.  Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.

Authors:  I Leeuwenburgh; P Scholten; T J Caljé; R J Vaessen; H W Tilanus; B E Hansen; E J Kuipers
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

4.  Laparoscopic Nissen fundoplication in the treatment of Barrett's esophagus - 10 years of experience.

Authors:  Marcin Migaczewski; Michał Pędziwiatr; Maciej Matłok; Andrzej Budzyński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-01-21       Impact factor: 1.195

5.  In Vivo Short-Term Topical Application of BAY 11-7082 Prevents the Acidic Bile-Induced mRNA and miRNA Oncogenic Phenotypes in Exposed Murine Hypopharyngeal Mucosa.

Authors:  Clarence T Sasaki; Sotirios G Doukas; Dimitra P Vageli
Journal:  Neoplasia       Date:  2018-03-09       Impact factor: 5.715

6.  The Progressive Mutagenic Effects of Acidic Bile Refluxate in Hypopharyngeal Squamous Cell Carcinogenesis: New Insights.

Authors:  Clarence T Sasaki; Sotirios G Doukas; Jose Costa; Dimitra P Vageli
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

7.  Biliary tumorigenic effect on hypopharyngeal cells is significantly enhanced by pH reduction.

Authors:  Sotirios G Doukas; Bruno Cardoso; Jacob I Tower; Dimitra P Vageli; Clarence T Sasaki
Journal:  Cancer Med       Date:  2019-06-07       Impact factor: 4.452

Review 8.  Bile reflux and hypopharyngeal cancer (Review).

Authors:  Dimitra P Vageli; Sotirios G Doukas; Panagiotis G Doukas; Benjamin L Judson
Journal:  Oncol Rep       Date:  2021-09-24       Impact factor: 3.906

9.  The in vivo preventive and therapeutic properties of curcumin in bile reflux-related oncogenesis of the hypopharynx.

Authors:  Sotirios G Doukas; Panagiotis G Doukas; Clarence T Sasaki; Dimitra Vageli
Journal:  J Cell Mol Med       Date:  2020-07-21       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.